How many investments has Sarsia Management AS made?

Sarsia Management AS has 47 tracked investments.

What stage does Sarsia Management AS invest at?

Sarsia Management AS invests at the Seed, Series A stages.

What is Sarsia Management AS's typical check size?

Sarsia Management AS typically writes checks of $190K – $475K.

Where is Sarsia Management AS located?

Sarsia Management AS is headquartered in Bergen, NO.

Does Sarsia Management AS lead rounds?

Yes, Sarsia Management AS leads investment rounds.

Who does Sarsia Management AS co-invest with?

Sarsia Management AS most often shares deals with Farvatn Venture, Eviny Ventures, Hadean Ventures, among 8 tracked co-investors.

Sarsia Management AS

Venture capital

Bergen · Seed–Series A · 14 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Sarsia Management AS

779 people in our graph share verified history with the Sarsia Management AS team — schools, employers, funds. One of them is your warm intro.

Birgitteunlockedknows Farzad Abdi-Dezfuli · together at Calluna Pharma (overlapped)

×5knows the team · via BI Norwegian Business School

×4knows the team · via Norwegian School of Economics (NHH)

knows the team · via Heimdall Power

knows the team · via Norwegian University of Science and Technology (NTNU)

✨ Fox Verdict

Investment thesis

Sarsia is an early-stage venture capital firm investing across two main areas: life sciences, targeting unmet medical needs where capital and expertise can turn laboratory research into effective patient treatments; and technology, energy and sustainability, backing founders and technologies that can accelerate the green transition and build sustainable companies. The firm emphasizes technologies that improve quality of life and society while reducing negative environmental impact, connecting strong science and solutions with competent capital. Drawing on a team with diverse backgrounds and perspectives, Sarsia takes on risk to create value and is one of the top-performing early-stage venture funds in the Nordic region.

Invests inAI & Machine Learning Biotech Cleantech Climate Tech Deep Tech Energy Hardware Healthtech IoT Medical Devices New Materials Semiconductors Europe Finland Norway Sweden

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series A

Check

$190K – $475K

Bergen, NO

Leads rounds

Leads

Instruments

Equity

Founded

2006

AUM

$130M

Tracked investments

Team · 14 people

from the firm's website & curated & public directories

Sveinung Hole· Managing Partner· Norwayin

Managing Partner with experience in business development, corporate finance and investment management, including turn-around processes, trade sales and IPO board roles. Previously headed Norway's largest research funding foundation before (re-)joining Sarsia.

s•••@sarsia.comreveal

Farzad Abdi-Dezfuli· Partner Life Sciences· Bergen, Vestland, Norwayin

Partner in Life Sciences with a pharmacology PhD from the University of Edinburgh and preclinical/clinical drug development experience at global pharma, plus 17 years commercializing medical and biotech projects.

f•••@sarsia.comreveal

Erlend Skagseth· Senior Partner· Norwayin

Senior Partner with 20 years of experience in R&D-based IPR, project and business development from Christian Michelsen Research, Forinnova and Sarsia Innovation, plus turnaround and international contract experience.

e•••@sarsia.comreveal

Farzaad Abdi-Dezfuli· Partner, Life Sciences

f•••@sarsia.comreveal

Henrik Solberg-Johansen· Partner Technology, Energy and Sustainability· Norwayin

Partner with 30 years of experience in commercialization, financing, restructuring and M&A. Former CFO of NORCE and TTS and a partner at EY, having led teams across Norway, Europe and Asia.

h•••@sarsia.comreveal

Hilde Holdhus· Partner· Norwayin

Partner focused on technology innovation, energy transition and environmental sustainability, with a background in physical oceanography and financial analysis. She sits on several Sarsia portfolio company boards.

h•••@sarsia.comreveal

Jon Trygve Berg· Partner Technology, Energy and Sustainability· Bergen, Vestland, Norwayin

Partner with 14 years of VC experience in technology companies and board seats at several portfolio firms. A mechanical engineer and authorised financial analyst with prior CEO and CTO roles at early-stage startups.

j•••@sarsia.comreveal

Jon-Kåre Hansen· Partner Technology, Energy and Sustainability· Norwayin

Partner with 20 years of R&D experience across instrumentation, telecom, banking and education software, plus management experience in SaaS and scale-ups. Holds a Dr.Ing. in applied physics from NTNU.

j•••@sarsia.comreveal

Marit Wick· Partner and CFO· Bergen, Vestland, Norwayin

Partner and CFO with 20 years of financial, administrative, strategic and M&A management experience across offshore, food, real estate and life science industrial companies.

m•••@sarsia.comreveal

Øivind Enger· Partner, Life Science· Norwayin

Partner in Life Science with a PhD in microbiology, over 13 years of research experience in molecular biology and fish disease, and years commercializing biology, aquaculture, medicine and biotech projects.

o•••@sarsia.comreveal

Maija Slaidiņa· Investment Manager, Life Science· Bergen, Vestland, Norwayin

Investment Manager in Life Science with over 15 years of international research experience and expertise in technology transfer and innovation management. Previously assistant director of a medical incubator.

m•••@sarsia.comreveal

Hans Hekland· Associate advisor· Norwayin

Advisor with 30 years of international business development and corporate finance experience across industry and venture capital, including stock exchange listings and M&A transactions.

h•••@sarsia.comreveal

Olav Skjervheim· Compliance· Norwayin

Compliance consultant with over three decades in investment banking at institutions including First Securities, Swedbank and SpareBank 1 Markets. Oversees regulatory compliance and governance for Sarsia's fund management.

o•••@sarsia.comreveal

Johan· Board Member of Sarsia Seed AS· Oslo, Oslo, Norwayin

Joined Investinor in 2020 after 15 years with fund investments at Innovation Norway and prior experience at DNB Asset Management. MBA from University of Bath, Executive Corporate Finance studies from NHH, and BBA from Pacific Lutheran University and Institute for European Studies Vienna. Primarily focuses on venture fund investments.

j•••@investinor.noreveal

What they invest in

from 10 of 47 portfolio companies

Healthtech ×6Biotech ×4Medical Devices ×4AI & Machine Learning ×3Cleantech ×3Climate Tech ×2Energy ×2Circular Economy ×1

HQs:Norway×6Sweden×1United States×1

Investments · 47 tracked

founders shown can be your intro path

Caedo Oncologycaedooncology.com

Caedo Oncology develops therapeutic antibodies for cancer treatment, leveraging deep immunology and antibody engineering expertise.

BiotechHealthtechLongevityMedical DevicesOslo, NO

Kjetil Hestdal(Co-founder and CEO)

Co-investorsFarvatn Venture

Calluna Pharmacallunapharma.com in

Completed patient enrollment in its Phase 2 AURORA trial.

Co-investorsP53 Invest Forbion Investinor

Cetasolcetasol.com in

Co-investorsShift4Good

Coegin Pharmacoeginpharma.com in

Coegin Pharma develops and commercializes advanced cosmetic peptide technologies for hair and skin care, targeting the global longevity and wellness market.

BiotechConsumerHealthtechWellness & FitnessLund, SE

Co-investorsVentac Partners

Elektelekt.com

Elekt provides a white-label customer platform for electricity and grid utilities, including a consumer app, a business portal, and a CRM/marketing hub for the utility's own team.

EnergyEnterprise SoftwareSaaS

Arnt Inge Sætern(Founder)in

Heimdall Powerheimdallpower.com in

Heimdall Power develops advanced sensors and software to enhance power grid visibility, safety, and responsiveness for grid operators globally.

AI & Machine LearningCleantechEnergyIoTCharlotte, US

Jørgen Festervoll(CEO)in

Co-investorsEviny Ventures Sprettert

Nisonicnisonic.com

Nisonic develops FAST-ICP software that uses transorbital ultrasound imaging and machine learning to non-invasively detect raised intracranial pressure by measuring optic nerve sheath properties.

AI & Machine LearningHealthtechMedical DevicesTrondheim, NO

Co-investorsHadean Ventures Investinor

Oculaudiooculaudio.com

Oculaudio develops hearing aids designed for aesthetic appeal and user-friendliness, targeting people with hearing loss who experience fatigue from concentration required in daily listening situations.

AI & Machine LearningHardwareHealthtechMedical Devices

Tom Austadin

Pacertoolpacertool.com in 𝕏

Pacertool develops a precision medicine system (PaCRTool) focused on heart failure therapy, aimed at helping clinicians select suitable patients, optimize treatment, and measure response.

Digital HealthHealthtechMedical Devices

Hans Henrik Odland(Founder)in

Co-investorsFarvatn Venture

Pluviapluviabiotech.com

Pluvia Biotech is a University of Bergen spin-out developing small molecule pharmacological chaperones that stabilize and correct misfolded proteins to rescue enzymatic activity in rare genetic loss-of-function disorders.

BiotechDeep TechHealthtechBergen, NO

Aurora Martinez(CTO)Willem van Weperen(CEO)Torgeir Vaage(CFO)in

Co-investorsInvestinor

Soiltechsoiltech.no in

Soiltech provides treatment, recycling, and disposal solutions for contaminated water and industrial waste across energy, aquaculture, and municipal sectors.

Circular EconomyCleantechClimate TechNorway, NO

Co-investorsGreat North Ventures Homegrown Capital Innova Memphis, Inc.

Xsensxsens.no

High accuracy clamp-on flow rate and phase fraction meter for gas, oil, water and drilling mud systems.

Co-investorsProVenture

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Apim Therapeutics AsAquilozBergenbio AsaBlue LimitC10 PharmaChargitectDelante HealthEnsoEnuaFlow ComputingGenesequeGreen Power HubHepmarinInsentioKeelspotMedstorm Innovation AsMitigrateMovelOffshore SensingProphylix Pharma AsQbeeScandinavian BiopharmaScreencancer AsSea Hawk Navigation AsSeafarm Solutions AsSeasmartSerca PharmaceuticalsSonoClear ASSorbwater AsTrisense AsVaccibody AsVestland Pharma ASVolusenseWeylandWindsim As

Portfolio news

latest coverage across their companies

COEGIN: Transitioned to commercial sales with new brand launches and secured financing for growth — TradingView News

Coegin Pharma · tradingview.com · Aug 19, 2026

Earnings call transcript: Soiltech ASA sees strong Q3 2025 growth, stock rises By Investing.com

Soiltech · investing.com · Oct 30, 2025

Frequently asked questions

How many investments has Sarsia Management AS made?: Sarsia Management AS has 47 tracked investments.
What stage does Sarsia Management AS invest at?: Sarsia Management AS invests at the Seed, Series A stages.
What is Sarsia Management AS's typical check size?: Sarsia Management AS typically writes checks of $190K – $475K.
What sectors does Sarsia Management AS focus on?: Sarsia Management AS focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Energy, Hardware, Healthtech, IoT, Medical Devices, New Materials, Semiconductors.
Where is Sarsia Management AS located?: Sarsia Management AS is headquartered in Bergen, NO.
Does Sarsia Management AS lead rounds?: Yes, Sarsia Management AS leads investment rounds.
Who does Sarsia Management AS co-invest with?: Sarsia Management AS most often shares deals with Farvatn Venture, Eviny Ventures, Hadean Ventures, among 8 tracked co-investors.

Similar investors

Qbic Fund

Qbic is an inter-university venture capital fund that turns technological breakthroughs from its partner universities, research institutes and hospitals into sustainable businesses.

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.

$250K

Range VC

Range is a venture capital firm that invests in founders building novel solutions in overlooked or challenging categories. The firm focuses on consensus founders with unique insights, backing companies at various stages across diverse sectors.

$1M – $3M

Cowin Capital Group

Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.

$1.4M – $50M

BDC Fund Investments (Fund-of-Funds)

This page is the analysis and research library of the Business Development Bank of Canada (BDC), publishing studies, surveys and reports on issues affecting small and medium-sized businesses in Canada.